Form SC 13G/A INCYTE CORP Filed by: WELLINGTON MANAGEMENT GROUP LLP

Go back to Form SC 13G/A INCYTE CORP Filed by: WELLINGTON MANAGEMENT GROUP LLP

Incyte (INCY) PT Lowered to $87 at RBC Capital, 'Buyers on Weakness'

February 8, 2022 3:54 PM EST

RBC Capital analyst Brian Abrahams lowered the price target on Incyte (NASDAQ: INCY) to $87.00 (from $90.00) while maintaining an Outperform rating and said they would buy on weakness.

The analyst commented, "4Q featured strong initial launch metrics for Opzelura, solid sales for INCY's core MF... More